Race and Gender Play Role in Patient Views About Clinical Research During COVID-19 Pandemic
CISCRP partnered with SubjectWell, a patient recruitment firm, polling 553 patients in the United States to review how race and gender impact clinical trial participation, during the COVID-19 pandemic.
Respondents report concerns about being exposed to COVID-19 if enrolled in a clinical trial. By gender, the survey found that men are less hesitant to participate in non-COVID-19 than women. Women place higher values on precautions such as being able to communicate with a study physician remotely. African American patients are more concerned with precautionary measures like limiting the number of site visits and having the ability to send lab samples from home compared to Caucasian patients.
For information about collaborating with CISCRP on research initiatives, contact Annick de Bruin, Senior Director, Research Services, at 617-725-2750, extension 400 or at email@example.com.